openPR Logo
Press release

U.S Polycystic Ovary Syndrome Treatment Market is Likely to be Worth a Cumulative US$ 313.2 Million by 2024

05-18-2017 02:39 PM CET | Health & Medicine

Press release from: Persistence Market Research

U.S Polycystic Ovary Syndrome Treatment Market is Likely to be

Prevalence of endocrine diseases in the US is on a rise as the country’s urban residents continue to bear the brunt of their sedentary lifestyles. Rising incidence of endometriosis, unexplained infertility and polycystic ovarian syndrome (PCOS) continues to alarm public health authorities across the US. Measures undertaken by non-profit organizations and US health regulatory bodies are promoting the awareness of PCOS treatments. Also, therapies for diseases associated with PCOS are being developed to bear out the unmet clinical needs of people suffering from such complications. Despite this, the demand for PCOS treatment continues to incur a sluggish growth across the US. Persistence Market Research’s recent publication estimates that the US$ 230 Mn PCOS treatment market in the US will exhibit a moderate value CAGR of 3.9% to reach US$ 313.2 Mn by the end of 2024.
The foremost growth inhibitor for polycystic ovary syndrome treatment market in the US is pending approval of drugs at the FDA. The US FDA continues to prolong the approval for drugs on polycystic ovary syndrome treatment. And, this has severely lowered the production of effective medicines, thereby impacting the adoption of PCOS treatment. Presently, no drugs have been approved by the FDA for direct treatment of PCOS. Physicians are thus providing drug prescriptions through off-label indications, which is incidentally diverting patients to generic drugs.

Titled as “Polycystic Ovary Syndrome Treatment Market: US Industry Analysis and Forecast, 2016-2024,” the report projects that in 2016, more than US$ 66 Mn worth of oral contraceptive drugs were consumed in the US polycystic ovary syndrome treatment market. Through 2024, oral contraceptives will be exhibiting a steady revenue growth at 5.3% CAGR, and will account for nearly one-third share of market value. Besides, the demand for insulin sensitizing agents is expected to close in on number of oral contraceptives consumed in the US PCOS treatment market during this forecast period. Furthermore, growing preference to advanced drugs will also boost the consumption of aromatase inhibitors & SERMs, revenues from which will reach US$ 49 Mn by 2024-end.

More than 47% of US polycystic ovary syndrome treatment market will be accounted by drug sales through hospital pharmacies. With hospitals as the largest distribution channel, nearly US$ 150 Mn worth of PCOS drugs will be sold through these pharmacies. Meanwhile, PCOS drug sales through e-commerce platforms are projected to showcase a value CAGR of 4.6%, higher than that of hospital pharmacies and other distribution channels such as fertility clinics, drug stores and over-the-top counters.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14317

Key companies partaking in the growth of the US polycystic ovary syndrome treatment market include Sanofi, Novartis AG, Merck KGaA, Teva Pharmaceutical Industries Limited, and AstraZeneca plc.

To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/14317

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S Polycystic Ovary Syndrome Treatment Market is Likely to be Worth a Cumulative US$ 313.2 Million by 2024 here

News-ID: 541038 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for PCOS

Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728 Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.
06-20-2024 | Health & Medicine
Fact.MR
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness. Get Free Sample Research Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10043 PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms